Intuitive Surgical (ISRG) — insider trading
Health Care · NASDAQ
Intuitive Surgical (ISRG) has 74 reported SEC Form 4 insider transactions in our data, including 35 open-market sales among the most recent 74 (latest 2026-09-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Option exercise / conversion (derivative) | 543 | — | $0 | Form 4 |
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Option exercise / conversion (derivative) | 546 | — | $0 | Form 4 |
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Open-market sale | 543 | $374.44 | $203.3K | Form 4 |
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Option exercise / conversion | 543 | $109.49 | $59.5K | Form 4 |
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Open-market sale | 546 | $374.44 | $204.4K | Form 4 |
| 2026-09-15 | Widman Fredrik | Officer (VP Corporate Controller) | Option exercise / conversion | 546 | $79.64 | $43.5K | Form 4 |
| 2026-09-11 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 25 | $365.79 | $9.1K | Form 4 |
| 2026-09-10 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $347.66 | $8.0K | Form 4 |
| 2026-09-09 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $350.20 | $8.1K | Form 4 |
| 2026-09-08 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 46 | $361.23 | $16.6K | Form 4 |
| 2026-08-21 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 77 | $375.57 | $28.9K | Form 4 |
| 2026-08-20 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 77 | $396.37 | $30.5K | Form 4 |
| 2026-08-19 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 77 | $394.26 | $30.4K | Form 4 |
| 2026-08-18 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 77 | $394.00 | $30.3K | Form 4 |
| 2026-08-17 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 77 | $390.67 | $30.1K | Form 4 |
| 2026-08-11 | GUTHART GARY S | Director | Open-market sale | 10,000 | $400.00 | $4.00M | Form 4 |
| 2026-08-11 | Ladd Amy L | Director | Open-market sale | 72 | $393.10 | $28.3K | Form 4 |
| 2026-08-10 | Ladd Amy L | Director | Open-market sale | 400 | $379.00 | $151.6K | Form 4 |
| 2026-08-10 | LOEB GARY | Officer (EVP & Chief Legal and Complian) | Open-market sale | 400 | $379.00 | $151.6K | Form 4 |
| 2026-07-31 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 28 | $351.00 | $9.8K | Form 4 |
| 2026-07-30 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 28 | $346.83 | $9.7K | Form 4 |
| 2026-07-29 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 28 | $360.21 | $10.1K | Form 4 |
| 2026-07-28 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 28 | $365.58 | $10.2K | Form 4 |
| 2026-07-27 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 28 | $344.00 | $9.6K | Form 4 |
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion (derivative) | 1,910 | — | $0 | Form 4 |
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Shares withheld for taxes / exercise cost | 947 | $411.55 | $389.7K | Form 4 |
| 2026-07-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion | 1,910 | — | $0 | Form 4 |
| 2026-06-12 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 25 | $414.13 | $10.4K | Form 4 |
| 2026-06-11 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $412.16 | $9.5K | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion (derivative) | 1,358 | — | $0 | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Shares withheld for taxes / exercise cost | 674 | $426.61 | $287.5K | Form 4 |
| 2026-06-10 | Rosa David J. | Director, Officer (Chief Executive Officer (CEO)) | Option exercise / conversion | 1,358 | — | $0 | Form 4 |
| 2026-06-10 | LOEB GARY | Officer (EVP & Chief Legal and Complian) | Open-market sale | 400 | $424.14 | $169.7K | Form 4 |
| 2026-06-10 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $424.14 | $9.8K | Form 4 |
| 2026-06-09 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $421.13 | $9.7K | Form 4 |
| 2026-06-08 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 23 | $420.12 | $9.7K | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Option exercise / conversion (derivative) | 5,625 | — | $0 | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Open-market sale | 5,625 | $420.55 | $2.37M | Form 4 |
| 2026-06-01 | Jeddi Iman | Officer (SVP & GM da Vinci Platforms &) | Option exercise / conversion | 5,625 | $77.00 | $433.1K | Form 4 |
| 2026-05-22 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $439.80 | $7.9K | Form 4 |
| 2026-05-21 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $446.04 | $8.0K | Form 4 |
| 2026-05-20 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $440.38 | $7.9K | Form 4 |
| 2026-05-19 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $440.70 | $7.9K | Form 4 |
| 2026-05-18 | Brosius Mark | Officer (EVP & Chief Mfg and Supply Cha) | Open-market sale | 18 | $422.47 | $7.6K | Form 4 |
| 2026-05-11 | LOEB GARY | Officer (EVP & Chief Legal and Complian) | Open-market sale | 400 | $446.95 | $178.8K | Form 4 |
| 2026-04-30 | GUTHART GARY S | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | BARRATT CRAIG H | Director | Grant / award / vesting (derivative) | 643 | — | $0 | Form 4 |
| 2026-04-30 | BARRATT CRAIG H | Director | Option exercise / conversion (derivative) | 750 | — | $0 | Form 4 |
| 2026-04-30 | BARRATT CRAIG H | Director | Option exercise / conversion | 750 | — | $0 | Form 4 |
| 2026-04-30 | Beery Joseph C | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | Beery Joseph C | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Beery Joseph C | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | CHEW LEWIS | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | CHEW LEWIS | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | CHEW LEWIS | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | Johnson Amal M | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Johnson Amal M | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | Kolli Sreelakshmi | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | Kolli Sreelakshmi | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Kolli Sreelakshmi | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | Ladd Amy L | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | Ladd Amy L | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Ladd Amy L | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | Leonard Keith R | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | Leonard Keith R | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Leonard Keith R | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | NACHTSHEIM JAMI K | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Grant / award / vesting (derivative) | 554 | — | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Option exercise / conversion (derivative) | 531 | — | $0 | Form 4 |
| 2026-04-30 | Reed Monica P | Director | Option exercise / conversion | 531 | — | $0 | Form 4 |
| 2026-04-29 | Ladd Amy L | Director | Open-market sale | 119 | $463.50 | $55.2K | Form 4 |
| 2026-04-28 | Ladd Amy L | Director | Open-market sale | 500 | $473.46 | $236.7K | Form 4 |
Ask the chat about ISRG's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Intuitive Surgical (ISRG).
Last updated 2026-09-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.